INOVIQ
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - Industrial WAINOVIQ (IIQ, formerly BARD1 Life Sciences BD1) is an Australian life sciences company focused on developing and commercialising non-invasive diagnostic tests for early detection of cancer.
Its proprietary technology platform is based on novel tumour markers with potential diagnostic and therapeutic applications across multiple cancers. The pipeline includes two development-stage autoantibody tests for early detection of lung and ovarian cancers, and a research-stage cancer vaccine under evaluation for treatment of cancer.
In July 2020, the company acquired Sienna Cancer Diagnostics and relocated its head office from Perth to Melbourne.
On 9 December 2021, the company changed its name from BARD1 Life Sciences to INOVIQ to represent the company's ‘intelligent innovation’ as it develops and commercialises an innovative portfolio of diagnostic and exosome-based products.
Lists and Charts
Public Companies - Industrial WA list sponsored by
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | INOVIQ | $1.6m |
203 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 31/10/23
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 552nd | INOVIQ | 4% | 72% |
1838 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEWS: Tagged in Board Moves October 11, 2023 | 11 Oct 2023 |
| NEW ROLE: David Williams, Non-Executive Chair | 11 Oct 2023 |
| NEWS: Tagged in Board Moves December 14, 2022 | 14 Dec 2022 |
| NEWS: Tagged in Board Moves October 6, 2022 | 06 Oct 2022 |
| NEW ROLE: Mark Edwards, Chief Financial Officer, Company Secretary | 06 Oct 2022 |
| UPDATED: Public Companies - Industrial WA list | 20 Dec 2021 |
| NEW ROLE: Greg Rice, Chief Scientific Officer | 16 Sep 2021 |
| NEW ROLE: Peter French, Strategic Technology Advisor | 16 Sep 2021 |
| NEW ROLE: Hinch Hinch, | 01 Sep 2021 |
| NEWS: Tagged in BARD1 raises $15m for cancer detection tests | 23 Jul 2021 |
